Products - Varicella zoster virus (VZV)

Indications  >  Infections  >  Parameter from A to Z

Order no.Antibody specificity/ reagent/ analyteIg classSubstrateSpeciesFormat
EI 2650-9601 A
Varicella zoster virus
(VZV)
IgA

semi-quantitative
96 x 01
EI 2650-9601 G
Varicella zoster virus
(VZV)
IgG

10/100/500/5000 IU/l
96 x 01
EI 2650-9601 M
Varicella zoster virus (VZV)
incl. IgG/RF absorbent
IgM

semi-quantitative
96 x 01
EI 2650-9601-1 G
Varicella zoster virus (VZV)
avidity determination
IgG

10/100/500/5000 IU/l
96 x 01
EI 2650-9601-2 M
Varicella zoster virus (VZV) glycoprotein
incl. IgG/RF absorbent
IgM

semi-quantitative
96 x 01
EI 2650-9601-L A
Varicella zoster virus (VZV)
antibody determination in CSF
IgA

5/25/50/100 U
96 x 01
EI 2650-9601-L G
Varicella zoster virus (VZV)
antibody determination in CSF
IgG

5/25/50/100/175/230 U
96 x 01
DN 2410-1601-11 G
DN 2410-6401-11 G
"TO.R.C.H. 10"
(Toxoplasma gondii, Rubella virus, CMV,
HSV-1, HSV-2, Bordetella pertussis, Chlamydia trachomatis,
Parvovirus B19, Treponema pallidum, VZV separately)
IgG

EUROLINE


16 strips
64 strips
FI 2650-1005 A
FI 2650-1010 A
FI 2650-1005 G
FI 2650-1010 G
FI 2650-1005 M
FI 2650-1010 M
FI 2650-1005 X
FK 2650-1005
Varicella zoster virus
(VZV)
IgA

IgG

IgM

avidity test

infected cells
EU 168
10 x 05 (test system)
10 x 10 (test system)
10 x 05 (test system)
10 x 10 (test system)
10 x 05 (test system)
10 x 10 (test system)
10 x 05 (test system)
10 x 05 (single slides)
FI 2822-1001-1 G
FI 2822-1002-1 G
FI 2822-1001-1 M *
FI 2822-1002-1 M *
Exanthema Profile 1
(consisting of 21 different substrates)
IgG

IgM

field A: verification BIOCHIP, HHV-6,
Rubella virus*, Measles virus,
Mumps virus
field B: VZV, EBV-CA, EBV-EA,
Treponema pallidum
field C: HSV-1 and -2, Coxsackie virus
type B1 and A9
field D: Echo virus type 7, Borrelia
afzelii, burgdorferi (CH), garinii
field E: CMV, Candida albicans,
krusei*, tropicalis*

10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)
FI 2824-1001-1 G
FI 2824-1002-1 G
FI 2824-1001-1 M *
FI 2824-1002-1 M *
Central Nervous System Profile 1
(consisting of 21 different substrates)
IgG

IgM

field A: verification BIOCHIP,
Rubella virus*, Measles virus,
Mumps virus, VZV
field B: Adenovirus type 3, EBV-CA,
Treponema pallidum,
Toxoplasma gondii
field C: HSV-1 and -2, Coxsackie virus
type B1 and A7
field D: Echo virus type 7, Borr. afzelii,
burgdorferi (CH), garinii
field E: CMV, Haemophilus influenzae*,
Listeria monocytogenes 1/2a und 4b

10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)
FI 2826-1001-1 G
FI 2826-1002-1 G
FI 2826-1001-1 M
FI 2826-1002-1 M
Infectious Arthritis Profile 1
(consisting of 13 different substrates)
IgG

IgM

field A: verification BIOCHIP, VZV,
Influenza virus type A (H1N1
and H3N2) and B
field B: Yersinia enterocolitica
O:3*, O:6*, O:9*,
Toxoplasma gondii
field C: Borrelia afzelii,
burgdorferi (CH), garinii,
Chlamydia trachomatis

10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)
CK 2650-0220-L G
CSQ pair of controls
anti-VZV (IgG)
IgG


2 x 2 ml, ready for use
CI 2650-0101 A
antibodies against Varicella zoster virus (VZV)
IgA positive control
IgA


0.1 ml
CI 2650-0101 Z
Varicella zoster virus (VZV)
negative control
IgA, IgG, IgM


0.1 ml
CI 2650-0101 G
antibodies against Varicella zoster virus (VZV)
IgG positive control
IgG


0.1 ml
CI 2650-0101 M
antibodies against Varicella zoster virus (VZV)
IgM positive control
IgM


0.1 ml
CI 2650-0101 H
high-avid antibodies against Varicella zoster virus (VZV)
IgG positive control
avidity test


0.1 ml
CI 2650-0101 X
low-avid antibodies against Varicella zoster virus (VZV)
IgG positive control
avidity test


0.1 ml